UBX domain protein 8, also known as UBXN8, is a member of the UBX domain-containing protein family, which is characterized by the presence of the UBX domain. This domain is known to interact with p97, a type of AAA+ ATPase that is involved in a variety of cellular processes including protein degradation, cell cycle regulation, and the stress response.Specifically, UBXN8 is implicated in the endoplasmic reticulum-associated degradation (ERAD) pathway, where it assists in the retrotranslocation of misfolded proteins from the endoplasmic reticulum (ER) to the cytosol for subsequent degradation by the proteasome. The ER is responsible for the proper folding and maturation of membrane-bound and secretory proteins. When proteins are misfolded or fail to assemble correctly, they can be toxic to the cell. The ERAD pathway is crucial for cellular homeostasis as it helps to maintain protein quality control and prevents the accumulation of potentially harmful proteins.
The UBX domain of UBXN8 mediates the interaction with p97/VCP (valosin-containing protein), which provides the necessary ATPase activity to extract misfolded proteins from the ER membrane. UBXN8, in coordination with other cofactors, recruits p97 to the site of action, thereby facilitating the dislocation of aberrant proteins.Although the specific details of UBXN8's involvement in various cellular pathways are not fully understood, its function within the ERAD mechanism is a subject of interest due to the significance of protein homeostasis in cellular health and disease. Misregulation of ERAD components, including UBXN8, could potentially contribute to various diseases such as neurodegeneration, cancer, and metabolic disorders.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
This compound induces ER stress by inhibiting N-linked glycosylation, potentially increasing UBXD8 expression as part of the UPR. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin causes ER stress by inhibiting the ER calcium ATPase, which might upregulate UBXD8 expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
It disrupts ER to Golgi transport, causing ER stress and possibly elevating UBXD8 levels. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
By inhibiting ceramide synthase, it could cause lipid dysregulation and upregulate UBXD8. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
This fatty acid synthesis inhibitor may induce lipid stress, possibly enhancing UBXD8 expression. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
Palmitate can induce ER stress, which may increase UBXD8 expression as a stress response. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
It is a chemical chaperone that reduces ER stress and may influence UBXD8 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
As a proteasome inhibitor, MG132 can induce proteotoxic stress, potentially upregulating UBXD8. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
It can trigger ER stress, leading to a potential increase in UBXD8 expression. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
By inhibiting the mevalonate pathway, simvastatin could induce ER stress and upregulate UBXD8. | ||||||